Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track Record
— Closing the gap between basic research and clinical application
— More than 50 percent of all funded projects received follow-up funding
ForTra gGmbH für Forschungstransfer der Else Kröner-Fresenius-Stiftung (ForTra gGmbH), a non-profit arm of Else Kröner-Fresenius Foundation, today published the successful track record of its latest funding projects. Since 2017, the organization has been supporting basic biomedical research projects in their efforts to accelerate their transfer into clinical practice. Read more…
BellaSeno Appoints Dr. Thomas Lingner as Chief Technology Officer and Inga Freyert as VP Quality and Regulatory Affairs
— Further expansion of management expertise to accelerate BellaSeno´s market entry
BellaSeno GmbH, an ISO 13485-certified medtech company developing resorbable scaffolds using additive manufacturing technologies, announced today that Dr. Thomas Lingner was appointed Chief Technology Officer and Inga Freyert was promoted to VP Quality and Regulatory Affairs.
MetrioPharm Establishes Scientific Advisory Board of Seasoned Immunology and Pediatric Experts
— The new advisors will supply expertise in immunology, pathology, inflammatory processes and in MetrioPharm’s lead indication Duchenne muscular dystrophy
— Advisors have previously collaborated with MetrioPharm on strategic and scientific projects
— Advisors bring expertise to further advance MetrioPharm´s pipeline
MetrioPharm AG, a clinical stage biotech company developing drugs for inflammatory and infectious diseases, today announced that it has established a Scientific Advisory Board (SAB). Read more…
